Home >Deals & Matter Corner>Deal>JSA advised IHH on its exit from Apollo Gleneagles PET-CT JV

JSA advised IHH on its exit from Apollo Gleneagles PET-CT JV

Deal
October 27, 2025

Kedaara Capital Fund II LLP sells its 100% stake in Sunbeam Lightweighting Solutions Private Limited

JSA acted for Parkway Healthcare (an IHH entity) on Parkway Healthcare’s divestment from its PET-CT joint venture with Apollo Hospitals.

The transaction was led by Lead Partner – Siddharth Mody, with support from Partner – Rohan Kumar and Senior Associate – Tanmayee Sahoo.

POST TAGS

Tags BusinessRestructuringIndia, CorporateAdvisoryIndia, CorporateLawFirmsIndia, HealthcareLawIndia, HealthcareTransactionsIndia, HospitalInvestmentIndia, JointVentureAdvisory, JSA Thought Leadership, JSA Transactions, LawFirmsForIPOs, LawFirmsIndia, Leading Law Firm India, Legal Advisory India, LegalAdvisoryIndia, MADealsIndia, StrategicDivestment

Rohan Kumar Partner

With over 15 years of experience, Rohan Kumar is a Partner at JSA focusing on mergers and acquisitions, private equity, and venture capital. He provides strategic counsel to leading multinational and Indian corporates on a variety of complex transactions across the media, technology, manufacturing, and healthcare sectors.

Siddharth Mody Partner

Siddharth Mody specialises in delivering comprehensive legal solutions for Mergers and Acquisitions (M&A), Private Equity, Venture Capital, Foreign Investment, Joint Ventures, Amalgamations, Asset Purchases, and Real Estate transactions.